| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/08/2003 | EP1272515A2 Immunoregulator |
| 01/08/2003 | EP1272514A1 Dna encoding human vanilloid receptor vr3 |
| 01/08/2003 | EP1272511A2 Molecules associated with human reproduction |
| 01/08/2003 | EP1272217A1 Use of inhibition of a gas6 function or of a gas6 receptor for preventing and treating a cardiovascular disease |
| 01/08/2003 | EP1272216A2 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias |
| 01/08/2003 | EP1272215A2 Pharmaceutical preparations comprising modified peptides |
| 01/08/2003 | EP1272214A1 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells |
| 01/08/2003 | EP1272213A2 Microbial delivery system |
| 01/08/2003 | EP1272210A1 Chimeric nontoxic mutants of enterotoxins as mucosal adjuvants for cell-mediated or humoral immunity |
| 01/08/2003 | EP1272205A1 Sialoadhesin factor-2 antibodies |
| 01/08/2003 | EP1272193A2 Synergistic methods and compositions for treating cancer |
| 01/08/2003 | EP1272044A1 Protein stabilised emulsions |
| 01/08/2003 | EP1098665B1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/08/2003 | EP0929579B1 Monoclonal antibodies against a human act and serine protease complex |
| 01/08/2003 | EP0646012B1 WOUND HEALING AND TREATMENT OF FIBROTIC DISORDERS BY TGFbeta-3 |
| 01/08/2003 | EP0607309B1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 01/08/2003 | CN1390258A Factor IX/factor IXa antibodies and antibody derivatives |
| 01/08/2003 | CN1390233A Antitumor antibodies, proteins, and uses thereof |
| 01/08/2003 | CN1390215A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 01/08/2003 | CN1390138A Novel use of antibodies as vaccines |
| 01/08/2003 | CN1390137A A Blocking monoclonal antibody to VLA-1 and its use for the treatment of inflammatory disorders |
| 01/08/2003 | CN1390136A Vaccine against nepatitis B virus and human papilloma virus |
| 01/08/2003 | CN1390130A Glucosamine and egg for reducing inflammation |
| 01/08/2003 | CN1389472A Immune conjugate of type-IV collagenase-resisting monoclonal antibody 3D6 and lidamycin for treating colorectal carcinoma and other digestive track tumors |
| 01/08/2003 | CN1389268A Hepatitis B DNA vaccine |
| 01/08/2003 | CN1098320C Process for extracting caroteness from carotene-contg. materials |
| 01/07/2003 | WO2002004664A2 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells |
| 01/07/2003 | US6504020 Isolated nucleic acids comprising Listeria dal and dat genes |
| 01/07/2003 | US6504013 Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody |
| 01/07/2003 | US6504012 Polyethylene glycol fractionation of impure gamma-globulin, treating with an organic solvent for inactivated envelope viruses, and heat treating to inactivate heat sensitive viruses, removing aggregates generated from heat treatment |
| 01/07/2003 | US6504007 GDNF receptor |
| 01/07/2003 | US6503882 Treatment of HIV |
| 01/07/2003 | US6503753 Method for the development of an HIV vaccine |
| 01/07/2003 | US6503514 Attenuated strains of mycobacteria |
| 01/07/2003 | US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 01/07/2003 | US6503512 Anti-AIDS immunomodulator complex |
| 01/07/2003 | US6503511 Derivatives of choline binding proteins for vaccines |
| 01/07/2003 | US6503510 As therapeutic agents for T cell tumors or B cell tumors (excluding myeloma) |
| 01/07/2003 | US6503503 Allogeneic cellular vaccine |
| 01/07/2003 | CA2415199A1 Genes and their genetic products pertinent to microsatellite instable (msi+) tumours |
| 01/07/2003 | CA2113363C Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 01/07/2003 | CA2055441C Her2 extracellular domain |
| 01/06/2003 | CA2392187A1 Combination preparation for the therapy of immunological diseases |
| 01/03/2003 | WO2003001204A2 Type 1 diabetes diagnostics and therapeutics |
| 01/03/2003 | WO2003000928A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 01/03/2003 | WO2003000922A2 Chimeric immunomodulatory compounds and methods of using the same |
| 01/03/2003 | WO2003000918A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 01/03/2003 | WO2003000907A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 01/03/2003 | WO2003000899A1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000894A1 Polynucleotide vaccine |
| 01/03/2003 | WO2003000878A2 Use of fkbp chaperones as expression tool |
| 01/03/2003 | WO2003000877A2 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | WO2003000851A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 01/03/2003 | WO2003000847A2 Membrane associated progesterone receptor |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000736A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 01/03/2003 | WO2003000729A2 Secreted polypeptide and their use in the treatment of bone disorders |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000721A2 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | WO2003000720A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | WO2003000687A1 Tyrosine kinase inhibitors |
| 01/03/2003 | WO2003000310A2 Nasal devices |
| 01/03/2003 | WO2003000284A1 Vaccine composition comprising a hydrotalcite-type compound |
| 01/03/2003 | WO2003000283A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | WO2003000232A2 Method for preparation of vesicles loaded with immunostimulator y oligodeoxynucleotides |
| 01/03/2003 | WO2003000227A2 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 01/03/2003 | WO2003000204A2 Multivalent mycoplasma bacterin |
| 01/03/2003 | WO2003000199A2 Ilt3 and ilt4-related compositions and methods |
| 01/03/2003 | WO2003000183A2 Method of treating atherosclerosis and other inflammatory diseases |
| 01/03/2003 | WO2003000117A2 Detection and treatment of prostate cancer |
| 01/03/2003 | WO2003000113A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2003000024A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |
| 01/03/2003 | WO2003000014A2 Spherical protein particles and methods of making and using them |
| 01/03/2003 | WO2002081661A3 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/03/2003 | WO2002080840A3 Immunity adjuvant containing a complexed metal cation and vaccine containing same |
| 01/03/2003 | WO2002072754A9 Mva expressing modified hiv envelope, gag, and pol genes |
| 01/03/2003 | WO2002066056A3 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 01/03/2003 | WO2002060919A9 Molecules with extended half-lives, compositions and uses thereof |
| 01/03/2003 | WO2002055676A3 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 01/03/2003 | WO2002048185A3 Method for identifying secreted chlamydia polypeptides by using a type iii secretion system of a gram-negative |
| 01/03/2003 | WO2002045735A3 Nrp-derived peptides useful for treating insulin-dependent diabetes mellitus |
| 01/03/2003 | WO2002045653A3 Combination radiation therapy and chemotherapy in conjuction with administration of growth factor receptor antibody |
| 01/03/2003 | WO2002044366A3 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 01/03/2003 | WO2002044202A3 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof |
| 01/03/2003 | WO2002028891A3 Listeria inocua, genome and applications |
| 01/03/2003 | WO2002026757A3 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/03/2003 | WO2002026209A3 Microparticles for delivery of the heterologous nucleic acids |
| 01/03/2003 | WO2002016429A3 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2002012501A3 Anti-dual integrin antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002012500A3 Anti-il-12 antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002009699A3 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 01/03/2003 | WO2002008264A3 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof |
| 01/03/2003 | WO2002005842A3 Preventing airway mucus production by administration of egf-r antagonists |
| 01/03/2003 | WO2002005791A3 Antitumor combination comprising an aromatase inhibitor and an egfr antagonist or inhibitor |
| 01/03/2003 | WO2002002131A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/03/2003 | WO2001098357A3 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 01/03/2003 | WO2001092528A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |